From: Paediatric focal intracranial suppurative infection: a UK single-centre retrospective cohort study
Neurological sequelae | < 6 months post-discharge (n = 92) | ≥6 months post-discharge (n = 92) | Neurological sequelae | < 6 months post-discharge (n = 92) | ≥6 months post-discharge (n = 92) |
---|---|---|---|---|---|
Any sequelae | 35 (38.0%) | 22 (23.9%) | Any sequelae | 35 (38.0%) | 22 (23.9%) |
Seizures | 10 (28.6%) | 11 (50%) | Nystagmus | 2 (5.7%) | 2 (9.1%) |
Hemiplegia | 6 (17.1%) | 4 (18.1%) | Torticollis | 2 (5.7%) | – |
Diplopia | 4 (11.4%) | 3 (13.6%) | Dysdiadochokinesis | 1 (2.9%) | – |
n.VII palsy | 4 (11.4%) | 3 (13.6%) | Hearing loss | 1 (2.9%) | 2 (9.1%) |
Speech abnormality | 4 (11.4%) | 1 (4.5%) | Hemianopia | 1 (2.9%) | 2 (9.1%) |
Gait abnormality | 3 (8.6%) | 3 (13.6%) | Neurodevelopmental delay | 1 (2.9%) | 1 (4.5%) |
Dysphasia | 3 (8.6%) | 3 (13.6%) | Memory difficulties | 1 (2.9%) | 2 (9.1%) |
Delayed motor development | 2 (5.7%) | – | Visual discrimination difficulty | 1 (2.9%) | – |
Hemiparesis | 2 (5.7%) | 2 (9.1%) | Learning difficulties | – | 2 (9.1%) |
Hydrocephalus | 2 (5.7%) | 3 (13.6%) | Concentration difficulties | – | 1 (4.5%) |
n. VI palsy | 2 (5.7%) | – | Cerebral palsy | – | 1 (4.5%) |
Neuropathic pain | 2 (5.7%) | 1 (4.5%) |